Histology of Gall Bladder

Intramuscular Injection Technique

The Nephron Functional Unit of Kidney

Abnormal Eye Lid Positions Ptosis

3D MRI of Human Brain

From fabric choices to layering, clothing tips to help you deal with menopausal hot flashes

Inguinal hernia repair without mesh, Desarda Repair, no recurrence, no pain, no mesh hernia surgery, hernia operation, no mesh, without mesh, hernia operation, hernia surgery, new method

Crohns Disease Patient Education

Diverticulitis Attack Surgery

http://www.landging.com/well-test-animation.html
This well test animation demonstrates new oil drilling technology.

This video is a simplified tutorial to teach how to read and understand chaest x-rays. It is for beginners

La palmitoiletanolamide (PeaVera, PeaPure, Palmidrol, Achille e altri PEA prodotti rappresenta una rivoluzione nel trattamento del dolore. Si tratta di un efficace analgesico naturale, senza effetti collaterali. La sua azione è stata documentata in molte centinaia di articoli scientifici. Il suo meccanismo è stato scoperto dalla professoressa Rita Levi Montalcini, premio Nobel per la medicina.

Qui è disponibile una breve introduzione su questa sostanza particolare. (Qui Informazioni per i medici) PEA è disponibile in Italia dal 2007 ed è stata classificata dal Ministero della Salute italiano come alimento dietetico per fini medici speciali.

This video narrates the story of a girl who travels to Iran for doing a nose surgery.

X-linked agammaglobulinemia (XLA), or Bruton agammaglobulinemia, is an inherited immunodeficiency disease caused by mutations in the gene coding for Bruton tyrosine kinase (BTK). The disease was first elucidated by Bruton in 1952, for whom the gene is named. BTK is critical to the maturation of pre–B cells to differentiating mature B cells. The BTK gene defect has been mapped to the long arm of the X chromosome at band Xq21.3 to Xq22, spanning 37.5kb with 19 exons forming 659 amino acids to complete the BTK cytosolic tyrosine kinase. A database of BTK mutations (BTKbase: Mutation registry for X-linked agammaglobulinemia) lists 544 mutation entries from 471 unrelated families showing 341 unique molecular events. No single mutation accounts for more than 3% of mutations in patients. In addition to mutations, a number of variants or polymorphisms have been found.

How to Treat Cuts & Scrapes | First Aid Training

10 Craziest Plastic Surgeries

Rapid Algorithm Review Ventricular Fibrillation

Benign prostatic hyperplasia (BPH), also known as benign prostatic hypertrophy, is a histologic diagnosis characterized by proliferation of the cellular elements of the prostate. Cellular accumulation and gland enlargement may result from epithelial and stromal proliferation, impaired preprogrammed cell death (apoptosis), or both. BPH involves the stromal and epithelial elements of the prostate arising in the periurethral and transition zones of the gland (see Pathophysiology). The hyperplasia presumably results in enlargement of the prostate that may restrict the flow of urine from the bladder. BPH is considered a normal part of the aging process in men and is hormonally dependent on testosterone and dihydrotestosterone (DHT) production. An estimated 50% of men demonstrate histopathologic BPH by age 60 years. This number increases to 90% by age 85 years. The voiding dysfunction that results from prostate gland enlargement and bladder outlet obstruction (BOO) is termed lower urinary tract symptoms (LUTS). It has also been commonly referred to as prostatism, although this term has decreased in popularity. These entities overlap; not all men with BPH have LUTS, and likewise, not all men with LUTS have BPH. Approximately half of men diagnosed with histopathologic BPH demonstrate moderate-to-severe LUTS. Clinical manifestations of LUTS include urinary frequency, urgency, nocturia (awakening at night to urinate), decreased or intermittent force of stream, or a sensation of incomplete emptying. Complications occur less commonly but may include acute urinary retention (AUR), impaired bladder emptying, the need for corrective surgery, renal failure, recurrent urinary tract infections, bladder stones, or gross hematuria. (See Presentation.) Prostate volume may increase over time in men with BPH. In addition, peak urinary flow, voided volume, and symptoms may worsen over time in men with untreated BPH (see Workup). The risk of AUR and the need for corrective surgery increases with age.

How Do We Breathe ?

A hemangioma (he-man-jee-O-muh) is a birthmark that most commonly appears as a rubbery, bright red nodule of extra blood vessels in the skin. A hemangioma grows during the first year of life, and then recedes over time. A child who had a hemangioma during infancy usually has little visible trace of the growth by age 10.